The Consent-First Market for Health Data
Consenta unlocks the value of health data ethically — giving patients control and a fair share, organisations a new revenue stream, and researchers a trusted, compliant source of real-world data.
The opportunity
Global real-world health data market by 2030
Annual growth in demand for real-world evidence
Of patients willing to share data when consent and reward are fair
Figures are illustrative market estimates for discussion purposes.
The problem
- Health data is valuable, but patients rarely consent to — or benefit from — its use.
- Organisations sit on data they cannot safely or compliantly monetise.
- Researchers struggle to source ethical, well-governed real-world data.
- Trust and transparency are missing from today’s data marketplaces.
The Consenta solution
- Patients grant explicit, granular consent and share in the proceeds.
- Organisations monetise data safely, with privacy protected by design.
- Buyers access consented, audit-ready datasets with full provenance.
- Every transaction is transparent and automatically settled.
Business model
Transaction share
Consenta takes a transparent platform share of every dataset sale, alongside patient and organisation payouts.
Recurring platform access
Organisations and buyers subscribe for ongoing access, tooling and support.
Aligned incentives
Revenue grows as more patients consent and more datasets transact — a compounding network effect.
Why Consenta wins
Trust by design
Consent, privacy protection and tamper-evident audit trails are built into every step.
Fair value sharing
Patients are paid automatically — a powerful differentiator that drives consent and loyalty.
Compliance-ready
Aligned with GDPR, HIPAA and Cyber Essentials expectations from day one.
Scalable model
A repeatable playbook to onboard organisations and buyers across regions and data types.
Let’s build the future of ethical health data
Reach out to explore partnership and investment opportunities.